3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Leukemia, Myeloid, Acute
27
Leukemia
22
Precursor Cell Lymphoblastic Leukemia-Lymphoma
7
Leukemia, Myelomonocytic, Acute
6
Leukemia, Monocytic, Acute
6
Leukemia, Megakaryoblastic, Acute
6
Leukemia, Erythroblastic, Acute
6
Myelodysplastic Syndromes
5
Anemia, Refractory, with Excess of Blasts
5
Lymphoma, Non-Hodgkin
4
Lymphoma, Follicular
4
Lymphoma
4
Leukemia, Promyelocytic, Acute
4
Leukemia, Myelomonocytic, Chronic
4
Neoplasms, Plasma Cell
3
Multiple Myeloma
3
Lymphoma, Large-Cell, Immunoblastic
3
Lymphoma, Large B-Cell, Diffuse
3
Leukemia, Myeloid, Chronic-Phase
3
Neutropenia
2
Lymphoma, B-Cell, Marginal Zone
2
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
2
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
2
Leukemia, Lymphocytic, Chronic, B-Cell
2
Congenital Abnormalities
2
Anemia, Refractory
2
Sarcoma, Synovial
1
Sarcoma
1
Rhabdomyosarcoma
1
Myeloproliferative Disorders
1
Interventions
Doxorubicin
25
Ifosfamide
22
Radiotherapy
17
Etoposide
11
Vincristine
10
Cyclophosphamide
10
Filgrastim
8
Dactinomycin
8
Trabectedin
7
Chemotherapy, Adjuvant
5
pazopanib
4
Cisplatin
4
Topotecan
3
Radiation
3
Neoadjuvant Therapy
3
Irinotecan
3
Granulocyte Colony-Stimulating Factor
3
Dacarbazine
3
sargramostim
2
etoposide phosphate
2
eribulin
2
Observation
2
Methotrexate
2
Mesna
2
Imatinib Mesylate
2
Gemcitabine
2
Epirubicin
2
Docetaxel
2
Dexrazoxane
2
Carboplatin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 3
×
Sarcoma
×
Idarubicin
×
Clear all
NCT00876031
2022-11-08
CWS-2007-HR
University Hospital Tuebingen
Phase 3
Completed
195 enrolled